105 related articles for article (PubMed ID: 19544542)
1. Predictive models of toxicity in external radiotherapy: dosimetric issues.
Fiorino C; Rancati T; Valdagni R
Cancer; 2009 Jul; 115(13 Suppl):3135-40. PubMed ID: 19544542
[TBL] [Abstract][Full Text] [Related]
2. Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
Valdagni R; Rancati T; Fiorino C
Cancer; 2009 Jul; 115(13 Suppl):3141-9. PubMed ID: 19544543
[TBL] [Abstract][Full Text] [Related]
3. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.
Skala M; Rosewall T; Dawson L; Divanbeigi L; Lockwood G; Thomas C; Crook J; Chung P; Warde P; Catton C
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):690-8. PubMed ID: 17379434
[TBL] [Abstract][Full Text] [Related]
4. Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer.
Fiorino C; Alongi F; Perna L; Broggi S; Cattaneo GM; Cozzarini C; Di Muzio N; Fazio F; Calandrino R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):29-35. PubMed ID: 19467803
[TBL] [Abstract][Full Text] [Related]
5. Dose-volume effects for normal tissues in external radiotherapy: pelvis.
Fiorino C; Valdagni R; Rancati T; Sanguineti G
Radiother Oncol; 2009 Nov; 93(2):153-67. PubMed ID: 19765845
[TBL] [Abstract][Full Text] [Related]
6. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer.
Chan LW; Xia P; Gottschalk AR; Akazawa M; Scala M; Pickett B; Hsu IC; Speight J; Roach M
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):69-77. PubMed ID: 18342454
[TBL] [Abstract][Full Text] [Related]
7. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity.
Fonteyne V; De Neve W; Villeirs G; De Wagter C; De Meerleer G
Radiother Oncol; 2007 Aug; 84(2):156-63. PubMed ID: 17692976
[TBL] [Abstract][Full Text] [Related]
8. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
Valdagni R; Rancati T; Fiorino C; Fellin G; Magli A; Baccolini M; Bianchi C; Cagna E; Greco C; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Vavassori V
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1065-73. PubMed ID: 18234449
[TBL] [Abstract][Full Text] [Related]
9. Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity.
Söhn M; Alber M; Yan D
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):230-9. PubMed ID: 17707277
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity.
Jani AB; Su A; Milano MT
Urology; 2006 Jan; 67(1):147-51. PubMed ID: 16413351
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
[TBL] [Abstract][Full Text] [Related]
12. Impact of dose and volume on rectal tolerance.
Gambacorta MA; Manfrida S; D'Agostino G; Digesù C; D'Onofrio I; Rosato H; Valentini V
Rays; 2005; 30(2):181-7. PubMed ID: 16294912
[TBL] [Abstract][Full Text] [Related]
13. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
[TBL] [Abstract][Full Text] [Related]
14. Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer.
Marzi S; Arcangeli G; Saracino B; Petrongari MG; Bruzzaniti V; Iaccarino G; Landoni V; Soriani A; Benassi M
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):41-9. PubMed ID: 17276615
[TBL] [Abstract][Full Text] [Related]
15. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
Strigari L; Arcangeli G; Arcangeli S; Benassi M
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
[TBL] [Abstract][Full Text] [Related]
16. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
[TBL] [Abstract][Full Text] [Related]
18. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.
Fonteyne V; Villeirs G; Lumen N; De Meerleer G
Radiother Oncol; 2009 Jul; 92(1):42-7. PubMed ID: 19356817
[TBL] [Abstract][Full Text] [Related]
19. Bladder and rectal toxicity of BeamCath application in radiotherapy of prostate cancer.
Hanssen S; Norum J
Anticancer Res; 2008; 28(5B):2865-8. PubMed ID: 19031926
[TBL] [Abstract][Full Text] [Related]
20. Erectile dysfunction after radiotherapy for prostate cancer.
Mendenhall WM; Henderson RH; Indelicato DJ; Keole SR; Mendenhall NP
Am J Clin Oncol; 2009 Aug; 32(4):443-7. PubMed ID: 19657239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
